ESR1 and triple-negative breast carcinoma: Importantly, cell lines representing triple negative breast cancers that lack clinically useful receptors (estrogen receptor, progesterone receptor, human epidermal growth factor-2) have higher endogenous levels of ROS and are thus more sensitive than their receptor-positive counterparts.